| 前收盘价格 | 9.37 |
| 收盘价格 | 9.24 |
| 成交量 | 133,964 |
| 平均成交量 (3个月) | 190,210 |
| 市值 | 171,030,448 |
| 市盈率 (P/E TTM) | 37.83 |
| 预期市盈率 (P/E Forward) | 5.63 |
| 价格/销量 (P/S) | 1.47 |
| 股市价格/股市净资产 (P/B) | 1.09 |
| 52周波幅 | |
| 利润日期 | 5 Nov 2026 |
| 营业毛利率 | -16.33% |
| 营业利益率 (TTM) | -9.64% |
| 稀释每股收益 (EPS TTM) | -0.840 |
| 季度收入增长率 (YOY) | 11.40% |
| 总债务/股东权益 (D/E MRQ) | 28.21% |
| 流动比率 (MRQ) | 2.82 |
| 营业现金流 (OCF TTM) | 6.63 M |
| 杠杆自由现金流 (LFCF TTM) | 9.20 M |
| 资产报酬率 (ROA TTM) | -1.20% |
| 股东权益报酬率 (ROE TTM) | -12.91% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Health Information Services (US) | 混合的 | 看跌 |
| Health Information Services (全球的) | 混合的 | 看跌 | |
| 股票 | OptimizeRx Corporation | 混合的 | 看跌 |
AIStockmoo 评分
-0.8
| 分析师共识 | NA |
| 内部交易活动 | NA |
| 价格波动 | -2.0 |
| 技术平均移动指标 | -2.5 |
| 技术振荡指标 | 2.0 |
| 相对估值 | NA |
| 财务健康 | NA |
| AI Insight | NA |
| 平均 | -0.83 |
|
OptimizeRx Corp is engaged in the healthcare market in the United States. It provides digital health messaging via electronic health records, providing a direct channel for pharmaceutical companies to communicate with healthcare providers and patients. The cloud-based solution supports patient adherence to medications by providing real-time access to financial assistance, prior authorization, education, and clinical information. Its product offerings are Financial Messaging, Brand and Clinical Messaging, Brand Support, and Patient Engagement. |
|
| 部门 | Healthcare |
| 行业 | Health Information Services |
| 投资方式 | Small Growth |
| 内部持股比例 | 14.98% |
| 机构持股比例 | 64.55% |
所有权
| 姓名 | 日期 | 持有股份 |
|---|---|---|
| Bullseye Asset Management Llc | 30 Jun 2026 | 258,311 |
该时间范围内无数据。
AI 技术分析
打开“技术”标签以生成最新分析。
投资组合